Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-02-22 @ 9:04 AM
Study NCT ID:
NCT05028751
Status:
TERMINATED
Last Update Posted:
2024-08-07
First Post:
2021-08-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)
Sponsor:
Kronos Bio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-25
First Submit QC Date:
None
Study First Post Date:
2021-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-11
Results First Submit QC Date:
None
Results First Post Date:
2024-08-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-11
Last Update Post Date:
2024-08-07
Last Update Post Date Type:
ACTUAL